Clinical trial
Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer
NCT00256308 · University of California, Irvine, Other · Terminated
Key facts
| NCT number | NCT00256308 |
|---|---|
| Title | Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer |
| Official title | A Phase II Study of Adjuvant Chemoradiation With Weekly Oxaliplatin in Patients With High Risk Resected Squamous Cell Carcinoma of the Head and Neck Region |
| Lead sponsor | University of California, Irvine, Other |
| Collaborators | Sanofi Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Oxaliplatin, Radiation |
| Enrollment | 6 |
| Start date | Feb 1, 2005 |
| Primary completion | May 1, 2010 |
| Completion | Oct 1, 2011 |
| First posted | Nov 21, 2005 |
| Last update posted | May 1, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: